Sandoz products

Basel, March 21, 2023 – Sandoz, a global leader in generic pharmaceuticals and biosimilars, today announced that the US Food and Drug Administration (FDA) approved …
Trends
Healthcare & Pharmaceuticals. Sandoz dials up product launch plans ahead of market debut. By Ludwig Burger and Paul Arnold. September 14, 202311:10 …
Basel, July 1, 2023 – Sandoz, a global leader in generic pharmaceuticals and biosimilars, today announced that the citrate-free high-concentration formulation (HCF) of its …
7 January 2015. Drugs Associated with Sandoz Inc. Sandoz Inc. manufactures, markets and/or distributes more than 161 drugs in the United States. …
Basel, March 5, 2024 – Sandoz, the global leader in generic and biosimilar medicines, today announced that the US Food and Drug Administration (FDA) approved Wyost ® …
Basel, October 24, 2023 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, today announced its year-to-date sales for the first nine …
Sandoz (SIX: SDZ; OTCQX: SDZNY) is the global leader in generic and biosimilar medicines, with a growth strategy driven by its Purpose: pioneering access for …
Founded in 1886, Sandoz was originally active in dye production before moving into pharmaceutical research during the First World War. After the merger with …
Aug 25, 2022. Ad hoc announcement pursuant to Art. 53 LR. Sandoz strategic review concludes that a separation of Sandoz by way of a 100% spin-off is in the best interest …
Basel, October 24, 2023 – Sandoz (SIX:SDZ/OTCQX:SDZNY), the global leader in generic and biosimilar medicines, today announced its year-to-date sales for the first nine …
See more